Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Umbilical cord-derived media is safe and effective for hair growth.

Women with PCOS tend to be less optimistic than those without it.

Environmental factors and exposure to toxins may contribute to male infertility by affecting sperm and hormone function.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Cernitin™, a pollen extract, was found to significantly reduce pain and inflammation in rats with chronic prostatitis, suggesting it could be a useful alternative to certain anti-inflammatory drugs.

Azathioprine may help treat severe alopecia areata, but more research is needed.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

Anabolic-androgenic steroids are dangerous and educating people about their risks is essential.

Ursolic acid from Ochrosia elliptica leaves may help manage PCOS symptoms.

High-dose radioactive iodine therapy does not harm fertility in thyroidectomy patients.

Hormonal therapy for transgender individuals carries health risks but is a personal choice.

Aging-related hormone changes affect voice quality, especially during puberty, menstruation, pregnancy, and menopause.

Acupressure improves quality of life in PCOS patients.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

Topical calcipotriol successfully treated hair loss in three patients with Alopecia Totalis.

African American women have a higher risk of preterm delivery than Caucasian women, and inflammatory stimuli affect gene expression in cells related to PCOS, showing a heightened inflammatory state in women with PCOS.

A 19-year-old male with delayed puberty was successfully treated for a condition that prevents normal hormone production.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

Steroid cell tumors in the ovary are rare, can produce testosterone causing symptoms, and are mainly treated with surgery.

Menopause is a clear hormonal transition in women, while men experience a gradual testosterone decline, with some needing lifestyle changes and targeted therapy.

Isoflavone may help manage PCOS symptoms, but its effectiveness is uncertain.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

Ion-paired risedronate significantly increases skin penetration without irritation compared to risedronate alone.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

A new microneedle patch and yellow light therapy significantly promote hair regrowth.

Early onset, severe types, nail changes, family history, and body hair loss worsen alopecia areata prognosis; sticking to treatment helps.

Scalp hair thinning in women with PCOS is linked to metabolic issues like abnormal glucose tolerance, high LDL, and skipped meals.

Preventing cancer involves lifestyle changes, vaccinations, early screening, and understanding cancer's molecular basis.